References and further reading
- Health & Safety Executive. EH40/2005 Workplace exposure limits. ISBN 978 0 7176 6446. Retrieved from http://www.hse.gov.uk/pubns/books/eh40.htm
- Health &Safety Executive, COSHH 2013. ISBN: 978 0 7176 6582 2. Retrieved from http://www.hse.gov.uk/pubns/books/l5.htm
- Mason, J., Blair, C., Sams, C., Jines, K., Grafit, S. J., Cushieri, J., & Baxter, J. (2005). Exposure to antineoplastic drugs in two UK hospital pharmacy units. The Annals of Occupational Hygiene, 49, 603–610.10.1093/annhyg/mei023
- Sottani, C., Porro, B., Imbrinai, M., & Minola, C. (2012). Occupational exposure to anti neoplastic drugs in four Italian health care settings. Toxicology Letters, 213, 107–115.10.1016/j.toxlet.2011.03.028
- Turci, R., Sottani, C., Ronchi, A., & Minoia, C. (2002). Biological monitoring of hospital personnel occupationally exposed to anti-neoplastic agents. Toxicology Letters, 13457, 64.
- World Health Organisation, International Agency for Research into Cancer. Retrieved from http://ec.europa.eu/health/scientific_committees/opinions_layman/en/electromagnetic-fields/glossary/ghi/iarc-classification.htm
- Ziegler, E., Mason, H. J., & Baxter, P. J. (2002). Occupational exposure to cytotoxic drugs in two UK oncology wards. Occupational and Environmental Medicine, 9, 608–612.10.1136/oem.59.9.608